上海复星医药(集团)股份有限公司
Shanghai Fosun Pharmaceutical Group Co LtdCNCNYShanghai Fosun Pharmaceutical Group Co Ltd (US:SFOSF) — Drug Manufacturers - Specialty & Generic. Número de bolsas en las que cotizan las acciones de la empresa: 3. En esta página: cotización y gráfico, dividendos, principales accionistas e historial del número de acciones.
Sobre la empresa
- Sitio web
- fosunpharma.com
- Sector
- Healthcare · Drug Manufacturers - Specialty & Generic
- Sede central
- Shanghai, China
- Consejero delegado
- Dr. Yi Liu
- Empleados
- 40 684
- Fundada
- 1994
- Acciones en circulación
- Capital flotante
- 1.63 mil M
- Capitalización bursátil
- 9.46 mil M HKD
- Insiders
- 43.02%
- Inversores institucionales
- 8.48%
- ISIN
- CNE100001M79
- Ratio de reparto
- 54.2%
- FCF
- 885 M CNY213%
- Deuda
- 39.5 mil M CNY18 a. de FCF
- Racha de dividendos
- 25 a.
- Beneficios, FCF y dividendos pagados — para los 12 meses hasta 31.03.2026 (el último informe de la compañía).
Descripción
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabolism and digestive systems, anti-infection, central nervous system, cardiovascular system, and APIs and intermediates. It also offers mRNA vaccines; medical aesthetic devices, such as medical aesthetic capital equipment, aesthetic dentistry, injectables, and personal care business units; mechanical ventilation devices under the Breas brand; and mobile pre-hospital care; professional in-hospital surgery and covers medical devices; and high-end surgical robots and medical consumables. In addition, the company provides diagnostics solutions comprising biochemical diagnostics, immune diagnostics, molecular diagnostics, microbiological diagnostics, pathological diagnostics, and chronic care management; and healthcare services, specialized medical treatment, online and offline medical services, and insurance services. Further, it engages in the operation of hospitals; and distribution and retail of healthcare products. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
Dividendos
Shanghai Fosun Pharmaceutical Group Co Ltd (600196) paga dividendos una vez al año. En los últimos 12 meses, se pagó 0.39 CNY por acción (pagos: 1). Eso representa aproximadamente el 1.63% del precio actual de la acción. Según el historial de pagos, se espera la próxima fecha ex-dividendo alrededor de 26.07.2027. Historial de dividendos ininterrumpido: 25 años.
| Fecha ex | Pago | Importe | % | Tipo | Ticker |
|---|---|---|---|---|---|
| 2026-07-27 | — | 0.3900 CNY | 1.6/1.6 % | anual | SHG:600196 |
| 2025-08-04 | — | 0.3200 CNY | 1.3/1.3 % | anual | SHG:600196 |
| 2024-08-06 | — | 0.2700 CNY | 1.1/1.1 % | anual | SHG:600196 |
| 2023-08-09 | — | 0.4200 CNY | 1.8/1.8 % | anual | SHG:600196 |
| 2022-06-16 | — | 0.5600 CNY | 2.3/2.3 % | anual | SHG:600196 |
Noticias de esta semana
Aún no hay noticias del sitio web de la empresa.
Principales accionistas
| Titular | Participación | Acciones | Fecha del informe |
|---|---|---|---|
| Wu (Yi Fang) (Director) | ≈0.04% | 1.06 M | 2018-12-31 |
